• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国免疫规划项目对11种儿童疫苗可预防疾病的影响:1950 - 2018年

Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950-2018.

作者信息

Pan Jinhua, Wang Yesheng, Cao Lingsheng, Wang Ying, Zhao Qi, Tang Shenglan, Gong Wenfeng, Guo Lei, Liu Zhixi, Wen Zexuan, Zheng Bo, Wang Weibing

机构信息

Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China.

National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

出版信息

Innovation (Camb). 2021 May 5;2(2):100113. doi: 10.1016/j.xinn.2021.100113. eCollection 2021 May 28.

DOI:10.1016/j.xinn.2021.100113
PMID:34557762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8454656/
Abstract

To evaluate the achievements of China's immunization program between 1950 and 2018, we chose 11 vaccine-preventable diseases (VPDs) as representative notifiable diseases and used annual surveillance data obtained between 1950 and 2018 to derive disease incidence and mortality trends. Quasi-Poisson and polynomial regression models were used to estimate the impacts of specific vaccine programs, and life-table methods were used to calculate the loss of life expectancy, years of life lost, and loss of working years. The total notification number for the 11 VPDs was 211,866,000 from 1950 to 2018. The greatest number occurred in 1959, with a total incidence of 1,723 per million persons. From 1978 to 2018, a substantial decline was observed in the incidence of major infectious diseases. The incidence of pertussis fell 98% from 126.35 to 1.58 per million, and the incidences of measles, meningococcal meningitis, and Japanese encephalitis fell 99%, 99%, and 98%, respectively. The regression models showed that most of the 11 diseases exhibited dramatic declines in morbidity after their integration into the Expanded Program on Immunization (EPI), while varicella and paratyphoid fever, which were not integrated into the EPI, showed increased morbidity. From 1978 to 2018, the total life expectancy for the 11 VPDs increased by 0.79 years, and similar results were obtained for different age groups. China has had great success in controlling VPDs in recent decades, and improving vaccination coverage is a key aspect of controlling VPDs in China.

摘要

为评估1950年至2018年间中国免疫规划的成就,我们选取了11种疫苗可预防疾病(VPD)作为具有代表性的法定报告疾病,并利用1950年至2018年期间获得的年度监测数据来推导疾病发病率和死亡率趋势。采用准泊松和多项式回归模型来估计特定疫苗计划的影响,并使用生命表方法来计算预期寿命损失、生命年损失和工作年损失。1950年至2018年期间,11种VPD的总报告数为2.11866亿例。数量最多的年份是1959年,总发病率为每百万人1723例。1978年至2018年期间,主要传染病的发病率大幅下降。百日咳发病率从每百万126.35例降至1.58例,下降了98%;麻疹、流行性脑脊髓膜炎和乙型脑炎的发病率分别下降了99%、99%和98%。回归模型显示,11种疾病中的大多数在纳入扩大免疫规划(EPI)后发病率显著下降,而未纳入EPI的水痘和副伤寒发病率则有所上升。1978年至2018年期间,11种VPD导致的总预期寿命增加了0.79岁,不同年龄组也得到了类似结果。近几十年来,中国在控制VPD方面取得了巨大成功,提高疫苗接种覆盖率是中国控制VPD的一个关键方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d974dcbcefba/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d29a6fa1a527/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/b467fb573b13/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/cebb402720d9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d414883d5d9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/b71aaa3c85d1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/42e2198c95ff/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d974dcbcefba/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d29a6fa1a527/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/b467fb573b13/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/cebb402720d9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d414883d5d9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/b71aaa3c85d1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/42e2198c95ff/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a2b/8454656/d974dcbcefba/gr6.jpg

相似文献

1
Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950-2018.中国免疫规划项目对11种儿童疫苗可预防疾病的影响:1950 - 2018年
Innovation (Camb). 2021 May 5;2(2):100113. doi: 10.1016/j.xinn.2021.100113. eCollection 2021 May 28.
2
Vaccine-preventable disease control in the People's Republic of China: 1949-2016.中华人民共和国疫苗可预防疾病控制:1949-2016 年。
Vaccine. 2018 Dec 18;36(52):8131-8137. doi: 10.1016/j.vaccine.2018.10.005. Epub 2018 Nov 26.
3
Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.1993 - 1998年澳大利亚的疫苗可预防疾病及疫苗接种覆盖率
Commun Dis Intell. 2000 Jun;Suppl:v-83.
4
Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes--Bangladesh, China, and India, 2006-2008.扩大脊髓灰质炎和麻疹监测网络,以建立急性脑膜炎和脑炎综合征监测 - 孟加拉国、中国和印度,2006-2008 年。
MMWR Morb Mortal Wkly Rep. 2012 Dec 14;61(49):1008-11.
5
The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.免疫规划对意大利 10 种疫苗可预防疾病的影响:1900-2015 年。
Vaccine. 2018 Mar 7;36(11):1435-1443. doi: 10.1016/j.vaccine.2018.01.065. Epub 2018 Feb 7.
6
Changes in epidemiological features of vaccine preventable infectious diseases among three eras of national vaccination strategies from 1953 to 2018 in Shanghai, China.1953年至2018年中国上海国家疫苗接种策略三个阶段中疫苗可预防传染病的流行病学特征变化
Lancet Reg Health West Pac. 2021 Jan 23;7:100092. doi: 10.1016/j.lanwpc.2021.100092. eCollection 2021 Feb.
7
Impact of social distancing on incidence of vaccine-preventable diseases, South Korea.社交距离措施对韩国疫苗可预防疾病发病的影响。
J Med Virol. 2021 Mar;93(3):1814-1816. doi: 10.1002/jmv.26614. Epub 2020 Nov 1.
8
Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017.中国儿童和青少年传染病:2008 年至 2017 年全国监测数据分析。
BMJ. 2020 Apr 2;369:m1043. doi: 10.1136/bmj.m1043.
9
An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China.中国贵州省扩大免疫规划中使用乙型脑炎疫苗的经济学评价。
Vaccine. 2012 Aug 10;30(37):5569-77. doi: 10.1016/j.vaccine.2012.05.068. Epub 2012 Jun 12.
10
The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic.2008 年至 2020 年日本 15 种疫苗可预防疾病的估计负担:COVID-19 大流行带来的转变。
J Infect Chemother. 2021 Oct;27(10):1482-1488. doi: 10.1016/j.jiac.2021.06.021. Epub 2021 Jul 5.

引用本文的文献

1
Development of a prediction rule for incomplete vaccination among children in Indonesia.印度尼西亚儿童疫苗接种不全预测规则的制定。
BMC Public Health. 2025 May 24;25(1):1915. doi: 10.1186/s12889-025-23109-0.
2
Effectiveness of catch-up vaccination from 2009 to 2011 on incidence of hepatitis B in Guangzhou, China: a time series analysis.2009年至2011年广州补种乙肝疫苗对乙肝发病率的影响:一项时间序列分析
BMC Public Health. 2025 Apr 25;25(1):1551. doi: 10.1186/s12889-025-22437-5.
3
Financing the introduction of new vaccines to the national immunisation programme in China: challenges and options for action.

本文引用的文献

1
Changes in newly notified cases and control of tuberculosis in China: time-series analysis of surveillance data.中国新报告病例变化与结核病控制:监测数据的时间序列分析。
Infect Dis Poverty. 2021 Feb 24;10(1):16. doi: 10.1186/s40249-021-00806-7.
2
Epidemiological characteristics and trends of notifiable infectious diseases in China from 1986 to 2016.1986 年至 2016 年中国法定传染病的流行病学特征和趋势。
J Glob Health. 2020 Dec;10(2):020803. doi: 10.7189/jogh.10.020803.
3
The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis.
为中国国家免疫规划引入新疫苗提供资金:面临的挑战与行动选择
BMJ Glob Health. 2025 Mar 24;10(3):e017970. doi: 10.1136/bmjgh-2024-017970.
4
Global vaccine coverage and childhood survival estimates: 1990-2019.全球疫苗接种覆盖率和儿童生存估计数:1990-2019 年。
Bull World Health Organ. 2024 Apr 1;102(4):276-287. doi: 10.2471/BLT.23.290129. Epub 2024 Feb 29.
5
Has COVID-19 Affected DTP3 Vaccination in the Americas?新冠疫情对美洲地区的百白破三联疫苗(DTP3)接种有影响吗?
Vaccines (Basel). 2024 Feb 25;12(3):238. doi: 10.3390/vaccines12030238.
6
Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.推进国家免疫规划:在中国乃至全球实现疫苗全覆盖的时代
Infect Dis Poverty. 2024 Mar 13;13(1):25. doi: 10.1186/s40249-024-01192-6.
7
The Effectiveness of National Expanded Program on Immunization With Hepatitis A Vaccines in the Chinese Mainland: Interrupted Time-Series Analysis.国家扩大免疫规划甲型肝炎疫苗接种的效果:中断时间序列分析。
JMIR Public Health Surveill. 2024 Feb 28;10:e53982. doi: 10.2196/53982.
8
How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.如何应对疫苗犹豫?来自中国国家乙肝免疫规划的经验教训。
Front Public Health. 2024 Jan 22;12:1286801. doi: 10.3389/fpubh.2024.1286801. eCollection 2024.
9
Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action.在中国推广高价值儿童联合疫苗:挑战与行动建议。
Infect Dis Poverty. 2024 Feb 1;13(1):12. doi: 10.1186/s40249-024-01181-9.
10
Construction of an indicator framework for vaccine inclusion in public health programs: A Delphi-entropy method study.构建公共卫生规划中疫苗纳入的指标框架:德尔菲-熵法研究。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2272539. doi: 10.1080/21645515.2023.2272539. Epub 2023 Oct 31.
自 1974 年扩大免疫规划(EPI)启动以来,低中等收入国家实验室确诊百日咳负担:系统评价和荟萃分析。
BMC Med. 2020 Aug 28;18(1):233. doi: 10.1186/s12916-020-01699-3.
4
Immunization: vital progress, unfinished agenda.免疫接种:至关重要的进展,尚未完成的议程。
Nature. 2019 Nov;575(7781):119-129. doi: 10.1038/s41586-019-1656-7. Epub 2019 Nov 6.
5
Determinants of vaccination uptake, and influenza vaccine effectiveness in preventing deaths and hospital admissions in the elderly population; Treviso, Italy, 2014/2015-2016/2017 seasons.疫苗接种率的决定因素,以及流感疫苗在预防老年人群死亡和住院方面的有效性;意大利特雷维索,2014/2015 - 2016/2017季节
Hum Vaccin Immunother. 2020;16(2):301-312. doi: 10.1080/21645515.2019.1661754. Epub 2019 Oct 7.
6
Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program.奥地利国家免疫计划引入 10 价肺炎球菌结合疫苗前后儿童和成人侵袭性肺炎球菌病。
PLoS One. 2019 Jan 10;14(1):e0210081. doi: 10.1371/journal.pone.0210081. eCollection 2019.
7
Vaccine-preventable disease control in the People's Republic of China: 1949-2016.中华人民共和国疫苗可预防疾病控制:1949-2016 年。
Vaccine. 2018 Dec 18;36(52):8131-8137. doi: 10.1016/j.vaccine.2018.10.005. Epub 2018 Nov 26.
8
The landscape of vaccines in China: history, classification, supply, and price.中国疫苗的概况:历史、分类、供应和价格。
BMC Infect Dis. 2018 Oct 4;18(1):502. doi: 10.1186/s12879-018-3422-0.
9
Collecting and using reliable vaccination coverage survey estimates: Summary and recommendations from the "Meeting to share lessons learnt from the roll-out of the updated WHO Vaccination Coverage Cluster Survey Reference Manual and to set an operational research agenda around vaccination coverage surveys", Geneva, 18-21 April 2017.收集和使用可靠的疫苗接种覆盖情况调查估计数:“分享实施世卫组织最新疫苗接种覆盖情况群组调查参考手册方面所汲取的经验教训和制定疫苗接种覆盖情况调查方面业务研究议程会议”总结和建议,2017 年 4 月 18-21 日,日内瓦。
Vaccine. 2018 Aug 16;36(34):5150-5159. doi: 10.1016/j.vaccine.2018.07.019. Epub 2018 Jul 21.
10
Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study.SARS疫情后首个十年中国传染病发病率的流行病学特征及变化:一项观察性趋势研究
Lancet Infect Dis. 2017 Jul;17(7):716-725. doi: 10.1016/S1473-3099(17)30227-X. Epub 2017 Apr 12.